Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verastem

6.08
-0.0900-1.46%
Post-market: 6.200.1200+1.97%19:41 EDT
Volume:2.02M
Turnover:12.33M
Market Cap:334.09M
PE:-1.74
High:6.33
Open:6.00
Low:5.88
Close:6.17
Loading ...

Verastem - FDA Granted Ftd for VS-7375 for Treatment of Kras G12d-Mutated Locally Advanced or Metastatic Pancreatic Cancer

THOMSON REUTERS
·
24 Jul

Verastem Inc - FDA Has Granted Fast Track Designation to VS-7375

THOMSON REUTERS
·
24 Jul

Verastem Oncology's VS-7375 Receives FDA Fast Track Designation for KRAS G12D-Mutated Pancreatic Cancer Treatment

Reuters
·
24 Jul

Verastem publishes RAMP 201 trial data in Journal of Clinical Oncology

TIPRANKS
·
12 Jul

Verastem Oncology Secures FDA Approval for Avutometinib Plus Defactinib Combination in KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer

Reuters
·
12 Jul

ADVISORY-Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn

Reuters
·
08 Jul

BRIEF-Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule

Reuters
·
08 Jul

Verastem Oncology Announces Stock Option Inducement Grants for New Employees Under Nasdaq Rule

Reuters
·
08 Jul

Verastem’s Phase 3 Study on Avutometinib and Defactinib: A Potential Game-Changer for Ovarian Cancer Treatment

TIPRANKS
·
05 Jul

BTIG Remains a Buy on Verastem (VSTM)

TIPRANKS
·
02 Jul

Verastem Oncology Secures FDA Approval for Avutometinib Plus Defactinib in KRAS-Mutated Low-Grade Serous Ovarian Cancer

Reuters
·
01 Jul

Verastem Is Maintained at Outperform by RBC Capital

Dow Jones
·
25 Jun

RBC Capital Keeps Their Buy Rating on Verastem (VSTM)

TIPRANKS
·
25 Jun

RBC Cuts Price Target on Verastem to $12 From $16, Keeps Outperform, Speculative Risk

MT Newswires Live
·
25 Jun

Top Executives Make Significant Moves with Verastem Stock!

TIPRANKS
·
25 Jun

Verastem Inc. CFO Daniel Calkins Reports Disposal of Common Shares

Reuters
·
25 Jun

BRIEF-Verastem Oncology Announces First Patient Dosed With VS-7375, An Oral KRAS G12D Inhibitor, In US Phase 1/2A Trial In KRAS G12D Advanced Solid Tumors

Reuters
·
25 Jun

Verastem announces first patient dosed with VS-7375

TIPRANKS
·
25 Jun

Verastem (VSTM) Gets a Buy from Mizuho Securities

TIPRANKS
·
06 Jun

Verastem Announces Strategic Plans in Investor Webcast

TIPRANKS
·
03 Jun